NEWS
Landmark public-private agreement for precision cancer medicine
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Oslo Cancer Cluster’s highlights 2020
Read a selection of our news from 2020.
Top news 2020 from Oslo Cancer Cluster's members
Read the top news from 2020 from a few of our members.
Positive results from Targovax’s skin cancer study
Update from Targovax on melanoma study shows responses in 7 of 20 patients.
Cancer drugs being tested to treat Covid-19
BerGenBio is testing the company’s cancer medicine as a treatment for Covid-19.
PDT/PCI application grant 2021
Radforsk funding call for photodynamic therapy and photochemical internalization (PDT/PCI) related research.
Mentor meeting: many roads to reach your goal
The road to becoming a researcher can take many surprising routes.
More precise cancer treatments with digital solutions
Why EHiN and digital health are important for faster development of new cancer treatments in Norway.
Norwegian invention to fight antibiotic resistance
A new Norwegian technology may help stop the increase of antibiotic multi-resistance.